Blacklisting Icahn: How Some Drug Companies Keep Out ActivistsBy
Pharmaceutical firms bar resale of stakes to activist managers
'I've never heard of such a thing,' activist Griggs says
When Concordia Healthcare Corp. agreed to issue a 14 percent stake to a private equity firm, the Canadian drug manufacturer tucked into the deal several layers of protection from shareholder activists.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.